Skip to content

BridgeBio Pharma BBIO Revenue recognized that was included in deferred income at the beginning of the period

Revenue recognized that was included in deferred income at the beginning of the period at other companies

Antero Resources logo
Antero ResourcesAR
$5.8M-7.0%
Ally Financial logo
Ally FinancialALLY
$225M+5.1%
Ally Financial logo
Ally FinancialALLY
$239M+0.4%
Hyatt Hotels logo
Hyatt HotelsH
$181M+7.7%
Moderna logo
ModernaMRNA
$37M+363%
Baxter International logo
Baxter InternationalBAX
$182M+46.8%

Segments

By product

See full
License and services revenue$2.1M-8.7%

Other financials

Income statement

See full
Revenue$194.5M+66.8%
Gross profit$184.6M+61.9%
Operating income-$106.0M-1.5%
Net income-$166.6M+1.8%
EPS (diluted)-$0.84+4.5%

Balance sheet

See full
Cash & equivalents$882.0M+62.5%
Total debt$3.3B+32,101%
Total equity-$2.3B-38.2%
Total assets$1.4B+55.5%

Cash flow

See full
Operating cash flow-$197.3M+1.0%
CapEx$69.0K
Free cash flow-$197.3M+0.9%

Valuation

See full
Market cap$12.98B+119%
Enterprise value$15.36B+178%
P/S22.4×-24.1×

Profitability

See full
Gross margin95.1%-0.2pp
Operating margin-90.5%-41.2pp
Net margin-125.9%-54.5pp
FCF margin-76.8%

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio1.5×-3.0×